Skip to main content
. 2022 Dec 3;11(3):95–103. doi: 10.51329/mehdiophthal1452

Table 2.

Comparison of baseline risk factors or stage of PVR grade C and change in BCDVA between the corresponding subgroups

Variable Subgroup IA
(n = 12)
Subgroup IIA
(n = 11)
P -value *
Risk factor (Score), Mean ± SD 2.3 ± 0.5 2.3 ± 0.5 0.825
Change in BCDVA (Snellen line), Mean ± SD 2.3 ±1.4 2.3 ± 1.1 0.928
Variable Subgroup IB
(n = 12)
Subgroup IIB
(n = 12)
P -value *
PVR C (Clock hours), Mean ± SD 3.3 ± 0.9 3.6 ± 0.7 0.550
Change in BCDVA (Snellen line), Mean ± SD 1.5 ±0.8 1.3 ±0.7 0.703

Abbreviations: n, number of eyes; SD, standard deviation; Change in BCDVA: change in best-corrected distance visual acuity measured in the number of Snellen lines gained or lost; PVR C, proliferative vitreoretinopathy grade C (*the Mann–Whitney U test was used). Note: Subgroup IA, subgroup in the control group with a high risk of developing PVR; Subgroup IIA, subgroup in the intervention group with a high risk of developing PVR; Subgroup IB, subgroup in the control group with established preoperative PVR grade C; Subgroup IIB, subgroup in the intervention group with established preoperative PVR grade C.